Evidence map›Paper›PMID 27793121›Full record

ArticleBMC infectious diseases2016

Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.

Tatiana Balaeva, Andrej M Grjibovski, Oleg Sidorenkov, Olga Samodova, Natalia Firsova, Anatoly Sannikov, Elise Klouman

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Tatiana BalaevaDepartment of Community Medicine, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromso, Norway. arkhangelsk.tatiana@rambler.ru.
Andrej M GrjibovskiNorthern State Medical University, Troitski Av. 51, Arkhangelsk, 163000, Russia.
Oleg SidorenkovDepartment of Community Medicine, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromso, Norway.
Olga SamodovaNorthern State Medical University, Troitski Av. 51, Arkhangelsk, 163000, Russia.
Natalia FirsovaArkhangelsk Regional Dermatovenerologic Dispensary, Sibiryakovtsev Street 2-1, Arkhangelsk, 163045, Russia.
Anatoly SannikovNorthern State Medical University, Troitski Av. 51, Arkhangelsk, 163000, Russia.
Elise KloumanDepartment of Community Medicine, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromso, Norway. elise.klouman@uit.no.ORCID 0000-0001-5970-5521
Northern State Medical University · RUUiT The Arctic University of Norway · NOArkhangel'skiy Klinicheskiy Onkologicheskiy Dispanser · RUInternational Institute of Management Arkhangelsk · RUNorth-Eastern Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHerpes simplex virus type 2 (HSV-2) infection is the most common cause of genital ulcer disease (GUD) worldwide. Mother to child transmission causes high morbidity and mortality among infants. Russia is on the brink of a generalized HIV-epidemic, but Arkhangelsk is still a low-prevalence area. HSV-2 infection is associated with a three-fold increased risk of HIV-infection. The evidence on the seroprevalence of HSV-2 in Russia is limited. The aim of this study was to assess HSV-2 seroprevalence and correlates among young adults in the city of Arkhangelsk.

methods1243 adults aged 18-39 years participated in a cross-sectional population-based study, recruited by a public opinion agency applying a quota sampling method to achieve a data set with similar age- and sex-distribution as the population in Arkhangelsk. All participants completed a standardized, self-administrated questionnaire and were tested for HSV-2. Associations between HSV-2 seropositivity and selected sociodemographic and behavioral factors, and self-reported history of sexually transmitted infections (STIs) were studied by multivariable logistic regression.

resultsHSV-2 seroprevalence was 18.8 %: 12.2 % (95 % confidence interval, CI 9.7-15.2) among men and 24.0 % (95 % CI 20.1-27.3) among women. Among men, HSV-2 positivity was associated with being divorced/widowed (OR = 2.85, 95 % CI 1.06-7.70), cohabitation (OR = 2.45, 95 % CI 1.07-5.62), and a history of STIs (OR = 2.11, 95 % CI 1.14-3.91). In women, HSV-2 positivity was associated with high income (OR = 3.11, 95 % CI 1.45-6.71) and having a lifetime number of sexual partners between 2 and 5 (OR = 2.72, 95 % CI 1.14-6.51), whereas sexual debut at age 18 years or older was inversely associated with the outcome (OR = 0.47, 95 % CI 0.31-0.72). In both sexes, increasing age was the strongest correlate of HSV-2 seropositivity in multivariable analyses.

conclusionThe HSV-2 seroprevalence was twice as high in women than in men and increased with age in both sexes, and similar to that reported from high-prevalence countries in Europe and the USA. The high prevalence of HSV-2 among women in childbearing age reveals the potential for HSV-2 transmission from mothers to infants and increased risk of acquisition HIV-infection; it also contributes to the burden GUD among both sexes. This emphasizes the public health implications of the HSV-2 epidemic in an urban population in North-West Russia.

Indexed as

AdolescentAdultCross-Sectional StudiesFemaleHerpes GenitalisHerpes SimplexHerpesvirus 2, HumanHIV InfectionsHumansLogistic ModelsMaleRussiaSeroepidemiologic StudiesSexual BehaviorSexually Transmitted DiseasesSexual PartnersCorrelates of HSV-2Eastern EuropeHerpes simplex virus type 2HSV-2Northwest RussiaPopulation-basedSelf-reported STIsSeroprevalence

Identifiers

PMID27793121
PMCPMC5084401
OpenAlexW2543359171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.